Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

L-374087: a new thrombin inhibitor developed at Merck & Co.

Sep. 12, 1997

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Sep. 11, 1997

New atypical antipsychotic agent from HMR

Sep. 11, 1997

LG Chemical characterizes new thrombin inhibitor

Sep. 10, 1997

SAR reported by Parke-Davis for series of N-type Ca2+ antagonists

Sep. 10, 1997

Resveratrol found in edible peanuts

Sep. 9, 1997

Ethnic differences in codeine's efficacy/side effects

Sep. 9, 1997

Voglibose preclinical results described at Japanese congress

Sep. 8, 1997

Sleep-promoting effects of L-846 demonstrated in insomniac patients

Sep. 8, 1997

Spotlight on adenosine A1 receptor agonists

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...